State of Science Summit- Multiple Myeloma: Chaired by Ehsan Malek, MD

State of Science Summit- Multiple Myeloma: Chaired by Ehsan Malek, MD

State of Science Summit- Multiple Myeloma: Chaired by Ehsan Malek, MD

Speakers

  • Ok-Kyong Chaekal, MD | University Hospitals Seidman Cancer Center
  • Molly Gallogly, MD, PhD | University Hospitals Seidman Cancer Center
  • Louis Williams, MD | Cleveland Clinic

Topics

  • Role of Proteasome Inhibitors in MM
  • Novel Agents in MM
  • BCMA-Targeted Therapy in MM
  • Sequencing of BCMA/Immunotherapy Targeted Agents
  • Monoclonal Antibodies in MM

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Matthew Brunner, MD, assistant professor, hematologic specialist, medical oncology, and palliative care, Department of Medicine, University of Wisconsin Carbone Cancer Center
Adam D. Cohen, MD, director, Myeloma Immunotherapy, associate professor in medicine, hematology/oncology, Abramson Cancer Center, University of Pennsylvania
Paul G. Richardson, MD
Amandeep Godara, MBBS
Sergio A. Giralt, MD
Surbhi Sidana, MD
Michael J. Fallon, MD
In this fifth episode of OncChats: Unpacking Data From Pivotal Trials in Multiple Myeloma, Hamza Hashmi, MD, reviews the implications of up-front vs delayed transplant on survival, quality of life, and risk of secondary malignancies in newly diagnosed, multiple myeloma.
Related Content